Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070

I Soerjomataram, F Bray - Nature reviews Clinical oncology, 2021 - nature.com
Cancer is currently the first or second most common contributor to premature mortality in
most countries of the world. The global number of patients with cancer is expected to rise …

[HTML][HTML] Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans

PJ Maver, M Poljak - Clinical microbiology and infection, 2020 - Elsevier
Background Cytology-based screening has been a cornerstone of cervical cancer
prevention for decades. Following extensive evidence demonstrating higher sensitivity and …

[HTML][HTML] Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative

D Singh, J Vignat, V Lorenzoni, M Eslahi… - The lancet global …, 2023 - thelancet.com
Background Tracking progress and providing timely evidence is a fundamental step forward
for countries to remain aligned with the targets set by WHO to eliminate cervical cancer as a …

[图书][B] Global strategy to accelerate the elimination of cervical cancer as a public health problem

World Health Organization - 2020 - books.google.com
Page 1 GLOBAL STRATEGY TO ACCELERATE THE ELIMINATION OF CERVICAL CANCER
AS A PUBLIC HEALTH PROBLEM Global strategy to accelerate the elimination of cervical …

[HTML][HTML] Estimates of the global burden of cervical cancer associated with HIV

D Stelzle, LF Tanaka, KK Lee, AI Khalil… - The lancet global …, 2021 - thelancet.com
Background HIV enhances human papillomavirus (HPV)-induced carcinogenesis. However,
the contribution of HIV to cervical cancer burden at a population level has not been …

[图书][B] WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: Use of mRNA Tests for Human Papillomavirus (HPV)

World Health Organization - 2021 - books.google.com
Page 1 WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical
cancer prevention, second edition: use of mRNA tests for human papillomavirus (HPV) Page …

[HTML][HTML] Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

M Arbyn, E Weiderpass, L Bruni… - The Lancet Global …, 2020 - thelancet.com
Background The knowledge that persistent human papillomavirus (HPV) infection is the
main cause of cervical cancer has resulted in the development of prophylactic vaccines to …

[HTML][HTML] Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle …

M Brisson, JJ Kim, K Canfell, M Drolet, G Gingras… - The Lancet, 2020 - thelancet.com
Summary Background The WHO Director-General has issued a call for action to eliminate
cervical cancer as a public health problem. To help inform global efforts, we modelled …

[HTML][HTML] Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries

K Canfell, JJ Kim, M Brisson, A Keane, KT Simms… - The Lancet, 2020 - thelancet.com
Background WHO is developing a global strategy towards eliminating cervical cancer as a
public health problem, which proposes an elimination threshold of four cases per 100 000 …

Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035

M Arnold, JY Park, MC Camargo, N Lunet, D Forman… - Gut, 2020 - gut.bmj.com
Objectives The incidence of gastric cancer continues to decrease globally, approaching
levels that in some populations could define it as a rare disease. To explore this on a wider …